|
Alliance Healthcare UK to enter into a solus wholesale agreement with MSD UK and Organon UK: 1st February 2022 We are pleased to announce that, as of 1st February 2022, Alliance Healthcare UK together with Alloga will become the only pre wholesaler / wholesale partnership to supply the MSD and Organon product portfolio to all pharmacies, hospitals and dispensing doctors in Great Britain and Northern Ireland. The majority of the Organon UK portfolio has divested from MSD as of June 2021. Purchases of the MSD and Organon portfolio will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will not be subject to Alliance Healthcare’s low spend surcharge. Eligible lines across these two portfolios will hold an applicable customer discount of 7%, which will appear on your invoice as per normal process. To receive the products from 1st February 2022, you can simply order from Alliance Healthcare in your usual manner. Both product portfolios will be available on a same day delivery service. If you would like to discuss these changes in more detail, please do not hesitate to contact your Forte Business Development Manager. Yours faithfully, Alliance Healthcare
Telephone: 0370 241 8717 Email: customerservice@alliance-healthcare.co.uk Website: Forte.uk.com |
Recommended
MDS Update November 2025
Alliance Healthcare UK to enter into a new solus wholesale agreement with Merz Pharma UK: 16 October 2025
MDS Update October 2025
Forxiga 8502 Member Rebate Letter Sept 25
MDS Update September 2025
AbbVie promotional information: Time to relieve the strain of IBS-C
MDS Update August 2025
Vydura Dispensing Doctors Communication
Alliance Healthcare UK to enter into a new reduced wholesale agreement with Eclosix Limited: July 2025
Alliance Healthcare UK to enter into a new solus wholesale agreement with Neon Diagnostics Ltd – 01 August 2025